Published 3 days ago • loading... • Updated 10 hours ago
Campaigners in final push for Skyclarys approval
Campaigners say the drug could cost about €280,000 per patient a year as the HSE weighs reimbursement at a final meeting.
8 Articles
8 Articles
Govt & HSE must ensure people living with Friedreich’s Ataxia have access to Skyclarys-Greens
Govt & HSE must ensure people living with Friedreich’s Ataxia have access to Skyclarys-Greens joseph.keogh@g… Mon, 08/24/2026 - 15:54 Carolyn Moore.jpg Image The Green Party has today called on the Government and the HSE to urgently work together to find a pathway to provide access to Skyclarys for people living with Friedreich’s Ataxia. Skyclarys, the first treatment approved in Europe for Friedreich’s Ataxia, can slow the progression of the…
Coverage Details
Total News Sources8
Leaning Left4Leaning Right0Center1Last Updated80% Left
Bias Distribution
- 80% of the sources lean Left
80% Left
L 80%
C 20%
Factuality
To view factuality data please Upgrade to Premium










